Your browser doesn't support javascript.
loading
Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathology.
Robinson, Carling G; Goodrich, Austin W; Weigand, Stephen D; Pham, Nha Trang Thu; Carlos, Arenn F; Buciuc, Marina; Murray, Melissa E; Nguyen, Aivi T; Reichard, R Ross; Knopman, David S; Petersen, Ronald C; Dickson, Dennis W; Utianski, Rene L; Whitwell, Jennifer L; Josephs, Keith A; Machulda, Mary M.
Afiliação
  • Robinson CG; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Goodrich AW; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Weigand SD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Pham NTT; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Carlos AF; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Buciuc M; Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.
  • Murray ME; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Nguyen AT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Reichard RR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Knopman DS; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Utianski RL; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Josephs KA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Machulda MM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
J Int Neuropsychol Soc ; : 1-9, 2024 Mar 25.
Article em En | MEDLINE | ID: mdl-38525671
ABSTRACT

OBJECTIVE:

To determine whether poorer performance on the Boston Naming Test (BNT) in individuals with transactive response DNA-binding protein 43 pathology (TDP-43+) is due to greater loss of word knowledge compared to retrieval-based deficits.

METHODS:

Retrospective clinical-pathologic study of 282 participants with Alzheimer's disease neuropathologic changes (ADNC) and known TDP-43 status. We evaluated item-level performance on the 60-item BNT for first and last available assessment. We fit cross-sectional negative binomial count models that assessed total number of incorrect items, number correct of responses with phonemic cue (reflecting retrieval difficulties), and number of "I don't know" (IDK) responses (suggestive of loss of word knowledge) at both assessments. Models included TDP-43 status and adjusted for sex, age, education, years from test to death, and ADNC severity. Models that evaluated the last assessment adjusted for number of prior BNT exposures.

RESULTS:

43% were TDP-43+. The TDP-43+ group had worse performance on BNT total score at first (p = .01) and last assessments (p = .01). At first assessment, TDP-43+ individuals had an estimated 29% (CI 7%-56%) higher mean number of incorrect items after adjusting for covariates, and a 51% (CI 15%-98%) higher number of IDK responses compared to TDP-43-. At last assessment, compared to TDP-43-, the TDP-43+ group on average missed 31% (CI 6%-62%; p = .01) more items and had 33% more IDK responses (CI 1% fewer to 78% more; p = .06).

CONCLUSIONS:

An important component of poorer performance on the BNT in participants who are TDP-43+ is having loss of word knowledge versus retrieval difficulties.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article